Viruses are the most common biological entities on the planet, and they have a huge impact on living beings by producing diseases and influencing their immune systems. Viruses are sequenced in less than 0.01 percent of cases, despite their widespread presence and significance. In terms of etiopathogenesis and the development of innovative therapies, the research of viral infectious diseases is experiencing significant developments at the moment. Virus genome sequencing is an important and fast evolving technology for diagnosing COVID-19 and understanding how the novel coronavirus spreads and is controlled.
Title : Dengue transmission and Aedes vector dynamics before, during and after COVID-19 travel restrictions
Ranjan Ramasamy, IDFISH Technology and University of Jaffna, United States
Title : Viral RNA structures as regulators of gene expression and therapeutic targets
Silvi Rouskin, Harvard Medical School, United States
Title : Novel functions of IRF3 in viral infection and inflammation
Saurabh Chattopadhyay, The University of Toledo, United States
Title : Therapeutic intervention of Bunyavirus induced hemorrhagic fever and cardiopulmonary disease
Mohammad Mir, Western University of Health Sciences, United States
Title : Why and how we discover and study the biology of viruses of micro-organisms in Aotearoa New Zealand
Robin Mac Diarmid, University of Auckland, New Zealand
Title : Antiviral action of aqueous extracts of propolis from scaptotrigona aff. postica against zica, chikungunya, and mayaro virus
Zucatelli, Instituto Butantan, Brazil